Gradient Investments LLC Laboratory Corp Of America Holdings Transaction History

Gradient Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$197.69 - $227.29 $2,767 - $3,182	14 Added 233.33%	20 $4,000
Q2 2023 Jul 11, 2023	BUY	$211.93 - $241.33 $1,271 - $1,447	6 New	6 $1,000
Q4 2022 Jan 10, 2023	BUY	$203.72 - $248.97 $1,426 - $1,742	7 New	7 $0
Q4 2018 Jan 18, 2019	SELL	$120.82 - $174.09 $7,370 - $10,619	-61 Closed	0 $0
Q1 2018 Apr 11, 2018	SELL	$161.53 - $178.11 $323 - $356	-2 Reduced 3.17%	61 $10,000
Q4 2017 Feb 07, 2018	BUY	$147.99 - $163.95 $9,323 - $10,328	63	63 $10,000

1.87M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $22.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.